Herceptin Hylecta

List of products in the National Drug Code with proprietary name herceptin hylecta. Trastuzumab is used to treat a certain type of breast cancer that makes more than usual amounts of a substance in your body (HER2 protein). Trastuzumab belongs to a class of medications known as monoclonal antibodies. It works by slowing or stopping the growth of cancer cells. This product also contains hyaluronidase, which helps your body absorb trastuzumab given by injection under the skin. This monograph is about the following trastuzumab products: trastuzumab (subcutaneous) and trastuzumab-hyaluronidase-oysk. These products are not the same as other trastuzumab products, including trastuzumab emtansine, or trastuzumab given by injection into a vein, and should not be used in place of each other.

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Labeler Name Product Type
50242-077Herceptin Hylecta Trastuzumab And Hyaluronidase-oyskInjection, SolutionSubcutaneousGenentech, Inc.Human Prescription Drug